pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
intismeran autogene · news · pharmadog
← back to intismeran autogene
News mentioning intismeran autogene
18
stories
2d
BMO most bullish on Merck's, bearish on BMS’ plans to contend with patent cliffs
biospace
3d
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
10d
Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge
biospace
21d
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
21d
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
23d
mRNA cancer vaccines’ biggest barriers to market
biopharma dive
26d
Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancer
biospace
27d
Moderna and Merck’s mRNA success fuels focus on ‘scaling out and scaling down’
biospace
Sep 1, 26
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
fiercebiotech
Aug 28, 26
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
biospace
Aug 27, 26
STAT+: The mystery of Moderna’s magic algorithm
stat
Aug 24, 26
STAT+: Inside Moderna and Merck’s cancer vaccine triumph
stat
Aug 20, 26
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
biospace
Aug 20, 26
Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact
fiercebiotech
Aug 19, 26
Moderna stock nearly doubles as Merck-partnered mRNA cancer vaccine meets Phase 3 goal
biospace
Aug 19, 26
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
biopharma dive
Aug 19, 26
Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccine
endpoints
Aug 18, 26
Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
fiercebiotech
